KKR Genetic Disorder L.P. insider trades
Open-market stock purchases and sales by KKR Genetic Disorder L.P., Unknown at BridgeBio Pharma, Inc, from SEC Form 4 filings since Jul 1, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +298%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BBIO BridgeBio Pharma, Inc: 1 buy, 5 sales, last May 12, 2025
Get free alerts when KKR Genetic Disorder L.P. files a new trade →